U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: April 28 - May 4, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: April 28 - May 4, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 04/29/2024
Location: Silver Spring, MD
Subject: Pharmaceutical Quality
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Archana Jatkar, Kathleen Davidson Jaeger, Sudarshan Jain (Indian Pharmaceutical Alliance); Pankaj Patel, Sharvil Patel (Zydus Lifesciences); Nilesh Gupta, Vinita Gupta (Lupin); Satish Reddy (Dr. Reddy's Laboratories Ltd); Dilip Shanghvi (Sun Pharma);

Event Date: 04/29/2024
Location: Virtual
Subject: Stanford Drug Discovery Symposium 2024; Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, government, and other registered attendees

Event Date: 04/29/2024
Location: Bethesda, MD
Subject: Dinner in Honor of the Indian Pharmaceutical Alliance Delegation
FDA Participant/Group: KIMBERLEE TRZECIAK; MARK ABDOO;
Non FDA Participant/Group: Nilesh Gupta, Vinita Gupta (Lupin); Catharine Young (White House Office of Science and Technology Policy); Rahul Gupta (Office of National Drug Control Policy); Pankaj Patel, Sharvil Patel (Zydus Lifesciences); Dilip Shanghvi (Sun Pharma); Satish Reddy (Dr. Reddy's Laboratories); Sripriya Ranganathan (Ambassador of India); Archana Jatkar, Sudarshan Jain (Indian Pharmaceutical Alliance);

Event Date: 04/30/2024
Location: Boston, MA
Subject: Yurchak Memorial Lecture Dinner
FDA Participant/Group: N/A
Non FDA Participant/Group: Several staff and students from Massachusetts General Hospital

Event Date: 05/01/2024
Location: Boston, MA
Subject: 13th Annual Peter M. Yurchak, MD Cardiology Grand Rounds Lectureship
FDA Participant/Group: N/A
Non FDA Participant/Group: Several staff and students from Massachusetts General Hospital

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 04/30/2024
Location: Washington, DC
Subject: International Food Information Council's Food and Health Survey and Communications Summit; Speaker: FDA Human Foods Program Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Leaders from industry, academia and government focused on food safety, nutrition, and sustainable food systems

Event Date: 05/02/2024
Location: College Park, MD
Subject: Partnership for Food Safety Education Spring Meeting; Speaker: Food Safety Education
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several attendees from the Partnership for Food Safety Education, academia, trade associations, federal government, and industry

Event Date: 05/02/2024
Location: Virtual
Subject: FDA Final Rule to Amend the Pre-harvest Agricultural Water Requirements in the Produce Safety Rule
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from across all state, local, tribal, and territorial departments of health and agriculture

Event Date: 05/02/2024
Location: College Park, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Dwayne Siekman, Pamela Siekman (Siekman, Siekman & Associates); Zen Honeycutt (Moms Across America); Kelly Ryerson (Glyphosate Facts); Michelle Perro (GMOScience);

Event Date: 05/03/2024
Location: Virtual
Subject: Food Chemical Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several attendees from industry trade associations

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 05/04/2024
Location: McLean, VA
Subject: Winston Health Policy Ball
FDA Participant/Group: ERIN O'QUINN;
Non FDA Participant/Group: Widely attended gathering

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

Event Date: 05/01/2024
Location: Virtual
Subject: Alliance for a Stronger FDA, FY25 Budget Series; Office of Regulatory Affairs
FDA Participant/Group: MICHAEL ROGERS;
Non FDA Participant/Group: Members of the Alliance for a Stronger FDA

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 04/29/2024
Location: Silver Spring, MD
Subject: Cooperative Efforts and Training in India
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of Indian Pharmaceutical Association (IPA)

Event Date: 04/30/2024
Location: Virtual
Subject: Stanford Drug Discovery Symposium 2024; Speaker: Advances and Innovations in CDER's Approach to Drug Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, government, and other registered attendees

Event Date: 05/01/2024
Location: Virtual
Subject: Listening Session
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the Combination Products Coalition (CPC)

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 04/30/2024
Location: New York, NY
Subject: Casdin Spotlight; Regulator’s Voice: Juggling Risk, Reward, and Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Event Date: 04/30/2024
Location: Virtual
Subject: Stanford Drug Discovery Symposium 2024; Speaker: Delivering on the Promise of Genetic Medicines
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, government, and other registered attendees

Event Date: 05/01/2024
Location: Virtual
Subject: Drug Information Association Webinar; Considerations to Support Global Regulatory Harmonization and Access of Cell and Gene Therapy Products to Patients
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and government stakeholders

Event Date: 05/02/2024
Location: Washington, DC
Subject: rEVOLUTION 2024 Symposium; Panelist: Emerging Technologies – Are We Reaching a Tipping Point?
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Event Date: 05/03/2024
Location: Virtual
Subject: Clinical Immunology Society; Speaker: Regulatory Considerations for Advancing Gene Therapy in the Clinic
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and healthcare stakeholders

Event Date: 05/03/2024
Location: Virtual
Subject: Precision Cardiovascular Care 2024 Symposium; Speaker: Regulatory Perspective and Facilitating Clinical Trial Design in Rare Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, academic, and healthcare stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 04/30/2024
Location: Silver Spring, MD
Subject: CDRH’s Regulatory Policy Advancements, Pilot Programs, and Initiatives from the Payor Communication Task Force
FDA Participant/Group: MICHELLE TARVER; MATTHEW HILLEBRENNER;
Non FDA Participant/Group: Mark Kessler, Paul Christie (Tachmed); Danielle de Jong, Jimmy Jackson, Joe Panetta, Laure Clark, Richard White, Zoe Bilis (Biocom); Gus Mouneimne (MeCo Diagnostics); Ahmed Zobi (Syntr Health Technologies); Daniel Lightfoot (Nanosonics Inc); Luca Springer (Cleancard);

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 04/29/2024
Location: Virtual
Subject: Higly Pathogenic Avian Influenza
FDA Participant/Group: N/A
Non FDA Participant/Group: Joe Reardon, Ted McKinney (National Association of State Departments of Agriculture (NASDA));

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 04/29/2024
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives of National Association of State Departments of Agriculture (NASDA)

Event Date: 05/03/2024
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representstives of American Veterinary Medical Association (AVMA)

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top